Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lianjun Shen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|December 6, 2005
Priming of T cells by exogenous antigen cross-presented on MHC class I moleculesLianjun Shen, Kenneth L Rock
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2004
Cellular protein is the source of cross-priming antigen in vivoLianjun Shen, Kenneth L Rock
Immunological Reviews|September 27, 2005
Cross-presentation: underlying mechanisms and role in immune surveillanceKenneth L Rock, Lianjun Shen
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell helpMaria Genevive H Hernandez, Lianjun Shen, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
CD40 on APCs is needed for optimal programming, maintenance, and recall of CD8+ T cell memory even in the absence of CD4+ T cell helpMaria Genevive H Hernandez, Lianjun Shen, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2009
Proteases in MHC class I presentation and cross-presentationKenneth L Rock, Diego J Farfán-Arribas, Lianjun Shen
Plos One|August 1, 2012
Assessment of roles for calreticulin in the cross-presentation of soluble and bead-associated antigensNatasha Del Cid, Lianjun Shen, Janice Belleisle, et al.
Trends in Cancer|November 23, 2021
Exploiting T cell signaling to optimize engineered T cell therapiesHaopeng Wang, Xianming Song, Lianjun Shen, et al.
Immunity|August 17, 2004
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivoLianjun Shen, Luis J Sigal, Marianne Boes, et al.
Clinical Case Reports|August 29, 2022
Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lfs* 23) and c.6521G > T (p.C2174F)Baolai Hua, Xiaobo Yan, Bin He, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|December 6, 2005
Priming of T cells by exogenous antigen cross-presented on MHC class I moleculesLianjun Shen, Kenneth L Rock
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2004
Cellular protein is the source of cross-priming antigen in vivoLianjun Shen, Kenneth L Rock
Immunological Reviews|September 27, 2005
Cross-presentation: underlying mechanisms and role in immune surveillanceKenneth L Rock, Lianjun Shen
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell helpMaria Genevive H Hernandez, Lianjun Shen, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
CD40 on APCs is needed for optimal programming, maintenance, and recall of CD8+ T cell memory even in the absence of CD4+ T cell helpMaria Genevive H Hernandez, Lianjun Shen, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2009
Proteases in MHC class I presentation and cross-presentationKenneth L Rock, Diego J Farfán-Arribas, Lianjun Shen
Plos One|August 1, 2012
Assessment of roles for calreticulin in the cross-presentation of soluble and bead-associated antigensNatasha Del Cid, Lianjun Shen, Janice Belleisle, et al.
Trends in Cancer|November 23, 2021
Exploiting T cell signaling to optimize engineered T cell therapiesHaopeng Wang, Xianming Song, Lianjun Shen, et al.
Immunity|August 17, 2004
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivoLianjun Shen, Luis J Sigal, Marianne Boes, et al.
Clinical Case Reports|August 29, 2022
Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lfs* 23) and c.6521G > T (p.C2174F)Baolai Hua, Xiaobo Yan, Bin He, et al.
Pageof 3